Inventor · disambiguated record
Jose Saro
Also filed as: SARO JOSE
2 granted patents·7 pending applications·6 citations·filing 2016–2023
53Inventor score
Top patents by PatentIndex Score
9 records- 0181US10596257B2Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Mar 24, 2020·5 cites·52 claims
- 0276US11013801B2Treatment methodHOFFMANN LA ROCHE·Filed 2016·Granted May 25, 2021·1 cites·28 claims
- 0376US2023372479A1Treatment methodHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0474US2023052521A1Treatment methodHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0571US2022054635A1Treatment methodHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0669US2021252144A1Treatment methodHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0757US2025367289A1Dosage regimen for a combination therapy consisting oftcr-engineered t-cells in combination with a pd-1 axis binding antagonistADAPTIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0855US2020376119A1Methods of treating cea-positive cancers using pd-1 axis binding antagonists and anti-cea/anti-cd3 bispecific antibodiesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0942US2020199230A1Treatment methodHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jose Saro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →